Safety Intervention for Improving Functioning in Suicidal Attempters
Launched by HOSPITAL CLINIC OF BARCELONA · Dec 15, 2022
Trial Information
Current as of February 05, 2025
Unknown status
Keywords
ClinConnect Summary
Design: STRONG is a single-centre experimental randomized clinical trial for suicidal attempters involving a safety planning intervention and 3- to 6-months follow-ups. This study will be carried out in the Bipolar and Depressive Disorders Unit, at Hospital Clínic de Barcelona. It will be rater-blinded and will include two parallel arms (1:1) in order to assess the efficacy of a safety planning intervention compared with treatment as usual. This project has been approved by the Ethical Committee of the Hospital Clinic of Barcelona and it will be carried up in accordance with the ethical pri...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age over 18 years old
- • Having attempted suicide
- • Provide written informed consent
- • No claustrophobia/metallic objects/implants
- Exclusion Criteria:
- • Intelligence quotient below 70 and impaired functioning
- • Any medical condition that could affect neuropsychological performance (such as neurological diseases) or a history of head trauma with loss of consciousness
- • Participation in any structured psychological intervention within the past 6 months
- • Patients who received electroconvulsive therapy within the past 6 months
- • Inability to give inform consent
Trial Officials
Iria Grande
Principal Investigator
IDIBAPS- Hospital Clinic de Barcelona
About Hospital Clinic Of Barcelona
The Hospital Clinic of Barcelona is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on multidisciplinary collaboration, the hospital integrates cutting-edge medical practices with rigorous scientific inquiry to enhance patient outcomes. As a prominent sponsor of clinical trials, the Hospital Clinic of Barcelona is dedicated to exploring new therapies and treatment modalities across various medical fields, fostering a culture of excellence in clinical research that ultimately aims to improve the quality of care for patients locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Barcelona, , Spain
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials